Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104882133> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2104882133 endingPage "82" @default.
- W2104882133 startingPage "75" @default.
- W2104882133 abstract "The therapeutic landscape for anticoagulation management is undergoing a shift from the use of traditional anticlotting agents such as heparins and warfarin as the only options to the growing adoption of newer target-specific oral anticoagulants (TSOACs) with novel mechanisms of action. Dabigatran, the first TSOAC approved for use in the United States, is a direct competitive inhibitor of thrombin. It has predictable kinetics, with an elimination half-life of 12 to 17 hours in healthy volunteers. Apixaban and rivaroxaban are selective inhibitors of factor Xa, and also display first-order kinetics. In younger healthy individuals, apixaban has an apparent half-life of approximately 12 hours, whereas rivaroxaban has an elimination half-life of 5 to 9 hours. Understanding the pharmacologic properties of these newer drugs can lead to better insights regarding their respective safety and efficacy profiles and their application in clinical practice. Laboratory assessments have been developed to measure the anticoagulant efficacy of these newer agents. However, the results of these tests can be highly variable, and are therefore not always useful for monitoring the anticoagulation effects of these agents. In addition, several strategies have been documented for the potential reversal of the anticoagulant effects of these drugs, from the temporary discontinuation of an agent before elective surgery to suggested emergency procedures in the case of major bleeding events. New, specific reversal agents for dabigatran, apixaban, and rivaroxaban are currently being developed, and dabigatran has received fast-track designation from the US Food and Drug Administration. Until comprehensive clinical guidelines are developed, institutions involved in emergency care should establish their own procedures for the management of patients undergoing anticoagulation who require emergency treatment. These protocols should include appropriate laboratory testing to assess anticoagulant activity as part of the inpatient workup if time allows, and the potential use of hemodialysis, prohemostatic agents, and reversal agents when available." @default.
- W2104882133 created "2016-06-24" @default.
- W2104882133 creator A5040117870 @default.
- W2104882133 date "2014-10-01" @default.
- W2104882133 modified "2023-10-17" @default.
- W2104882133 title "Managing Bleeding and Emergency Reversal of Newer Oral Anticoagulants: A Review for Primary Care Providers" @default.
- W2104882133 cites W1581215160 @default.
- W2104882133 cites W1959502336 @default.
- W2104882133 cites W1984637143 @default.
- W2104882133 cites W2005707364 @default.
- W2104882133 cites W2014822095 @default.
- W2104882133 cites W2031717872 @default.
- W2104882133 cites W2032041117 @default.
- W2104882133 cites W2035065430 @default.
- W2104882133 cites W2041195426 @default.
- W2104882133 cites W2044499278 @default.
- W2104882133 cites W2073510057 @default.
- W2104882133 cites W2101863341 @default.
- W2104882133 cites W2105435036 @default.
- W2104882133 cites W2106063034 @default.
- W2104882133 cites W2106828417 @default.
- W2104882133 cites W2115961889 @default.
- W2104882133 cites W2137914777 @default.
- W2104882133 cites W2152623033 @default.
- W2104882133 cites W2154183176 @default.
- W2104882133 cites W2158593099 @default.
- W2104882133 cites W2481569543 @default.
- W2104882133 doi "https://doi.org/10.3810/hp.2014.10.1144" @default.
- W2104882133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25502131" @default.
- W2104882133 hasPublicationYear "2014" @default.
- W2104882133 type Work @default.
- W2104882133 sameAs 2104882133 @default.
- W2104882133 citedByCount "2" @default.
- W2104882133 countsByYear W21048821332019 @default.
- W2104882133 countsByYear W21048821332021 @default.
- W2104882133 crossrefType "journal-article" @default.
- W2104882133 hasAuthorship W2104882133A5040117870 @default.
- W2104882133 hasConcept C126322002 @default.
- W2104882133 hasConcept C141071460 @default.
- W2104882133 hasConcept C177713679 @default.
- W2104882133 hasConcept C2776301958 @default.
- W2104882133 hasConcept C2778205648 @default.
- W2104882133 hasConcept C2778661090 @default.
- W2104882133 hasConcept C2778715236 @default.
- W2104882133 hasConcept C2778810321 @default.
- W2104882133 hasConcept C2779161974 @default.
- W2104882133 hasConcept C2780035454 @default.
- W2104882133 hasConcept C2780638905 @default.
- W2104882133 hasConcept C71924100 @default.
- W2104882133 hasConcept C98274493 @default.
- W2104882133 hasConceptScore W2104882133C126322002 @default.
- W2104882133 hasConceptScore W2104882133C141071460 @default.
- W2104882133 hasConceptScore W2104882133C177713679 @default.
- W2104882133 hasConceptScore W2104882133C2776301958 @default.
- W2104882133 hasConceptScore W2104882133C2778205648 @default.
- W2104882133 hasConceptScore W2104882133C2778661090 @default.
- W2104882133 hasConceptScore W2104882133C2778715236 @default.
- W2104882133 hasConceptScore W2104882133C2778810321 @default.
- W2104882133 hasConceptScore W2104882133C2779161974 @default.
- W2104882133 hasConceptScore W2104882133C2780035454 @default.
- W2104882133 hasConceptScore W2104882133C2780638905 @default.
- W2104882133 hasConceptScore W2104882133C71924100 @default.
- W2104882133 hasConceptScore W2104882133C98274493 @default.
- W2104882133 hasIssue "4" @default.
- W2104882133 hasLocation W21048821331 @default.
- W2104882133 hasLocation W21048821332 @default.
- W2104882133 hasOpenAccess W2104882133 @default.
- W2104882133 hasPrimaryLocation W21048821331 @default.
- W2104882133 hasRelatedWork W2016226059 @default.
- W2104882133 hasRelatedWork W2032118176 @default.
- W2104882133 hasRelatedWork W2037830341 @default.
- W2104882133 hasRelatedWork W2399023211 @default.
- W2104882133 hasRelatedWork W2399439482 @default.
- W2104882133 hasRelatedWork W2741829680 @default.
- W2104882133 hasRelatedWork W2750836949 @default.
- W2104882133 hasRelatedWork W2800941304 @default.
- W2104882133 hasRelatedWork W2908436399 @default.
- W2104882133 hasRelatedWork W4228999874 @default.
- W2104882133 hasVolume "42" @default.
- W2104882133 isParatext "false" @default.
- W2104882133 isRetracted "false" @default.
- W2104882133 magId "2104882133" @default.
- W2104882133 workType "article" @default.